Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Preleukemia × Sertraline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Leukemia 2 Preleukemia 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Hematologic Diseases 1 Cytopenia 1 Bone Marrow Diseases 1 Anemia 1

Interventions

venetoclax 1 spartalizumab 1 sabatolimab 1 lintuzumab 1 fludarabine 1 Sertraline 1 Melphalan 1 Lenalidomide 1 Decitabine 1 Biopsy 1 Azacitidine 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02452983 2022-06-02

SS1

Baylor College of Medicine

Phase 1 Terminated

Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Bone Marrow Diseases, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡